NCT05076591 2024-10-30
IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Suspended
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Beta Pharma (Suzhou) Co., Ltd.